Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Case Report

Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression

Authors: Christos Vaklavas, Elsa P Sotelo-Rafiq, Jordan Lovy, Miguel A Escobar, Apostolia M Tsimberidou

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

An 80-year-old man with no history of an immune-compromising disorder was diagnosed with progressive multifocal leukoencephalopathy (PML). He presented with dysphagia and left-sided weakness; magnetic resonance imaging demonstrated marked signal abnormality in the subcortical white matter of the left frontal lobe and in the posterior limb of the right internal capsule. Polymerase chain reaction (PCR) analysis of the cerebrospinal fluid (CSF) was negative for John Cunningham (JC) virus. On brain biopsy, foamy macrophages infiltrating the white matter were identified, staining positive for anti-simian virus 40 antibodies. Postoperatively, PCR for JC viral DNA in the CSF was positive, establishing the diagnosis of PML. Extensive investigation for an occult immunocompromising disorder was negative. The patient's neurologic deficits rapidly increased throughout his hospital stay, and he died 3.5 months after his diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koralnik IJ: New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004, 17: 365-370. 10.1097/00019052-200406000-00019PubMedCrossRef Koralnik IJ: New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004, 17: 365-370. 10.1097/00019052-200406000-00019PubMedCrossRef
2.
go back to reference Koralnik IJ: Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol 2006, 60: 162-173. 10.1002/ana.20933PubMedCrossRef Koralnik IJ: Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol 2006, 60: 162-173. 10.1002/ana.20933PubMedCrossRef
3.
go back to reference Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P: Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005, 353: 362-368. 10.1056/NEJMoa051586PubMedCrossRef Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P: Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005, 353: 362-368. 10.1056/NEJMoa051586PubMedCrossRef
4.
go back to reference Kleinschmidt-DeMasters BK, Tyler KL: Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005, 353: 369-374. 10.1056/NEJMoa051782PubMedCrossRef Kleinschmidt-DeMasters BK, Tyler KL: Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005, 353: 369-374. 10.1056/NEJMoa051782PubMedCrossRef
5.
go back to reference Dalianis T, Ramqvist T, Andreasson K, Kean JM, Garcea RL: KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol 2009, 19: 270-275. 10.1016/j.semcancer.2009.04.001PubMedCrossRef Dalianis T, Ramqvist T, Andreasson K, Kean JM, Garcea RL: KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol 2009, 19: 270-275. 10.1016/j.semcancer.2009.04.001PubMedCrossRef
6.
go back to reference Astrom KE, Mancall EL, Richardson EP Jr: Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958, 81: 93-111. 10.1093/brain/81.1.93PubMedCrossRef Astrom KE, Mancall EL, Richardson EP Jr: Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958, 81: 93-111. 10.1093/brain/81.1.93PubMedCrossRef
7.
go back to reference Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH: Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1: 1257-1260. 10.1016/S0140-6736(71)91777-6PubMedCrossRef Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH: Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1: 1257-1260. 10.1016/S0140-6736(71)91777-6PubMedCrossRef
8.
go back to reference Berger JR, Kaszovitz B, Post MJ, Dickinson G: Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 1987, 107: 78-87.PubMedCrossRef Berger JR, Kaszovitz B, Post MJ, Dickinson G: Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 1987, 107: 78-87.PubMedCrossRef
9.
go back to reference Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH: Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009, 48: 1459-1466. 10.1086/598335PubMedCrossRef Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH: Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009, 48: 1459-1466. 10.1086/598335PubMedCrossRef
10.
go back to reference Gheuens S, Pierone G, Peeters P, Koralnik IJ: Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81: 247-254. 10.1136/jnnp.2009.187666 Gheuens S, Pierone G, Peeters P, Koralnik IJ: Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81: 247-254. 10.1136/jnnp.2009.187666
11.
go back to reference Rea IM, Alexander HD, Crockard AD, Morris TC: CD4 lymphopenia in very elderly people. Lancet 1996, 347: 328-329.PubMed Rea IM, Alexander HD, Crockard AD, Morris TC: CD4 lymphopenia in very elderly people. Lancet 1996, 347: 328-329.PubMed
12.
go back to reference Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, Adelsberger JW, Metcalf JA, Polis MA, Kovacs SJ, et al.: Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 2008, 112: 287-294. 10.1182/blood-2007-12-127878PubMedPubMedCentralCrossRef Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, Adelsberger JW, Metcalf JA, Polis MA, Kovacs SJ, et al.: Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 2008, 112: 287-294. 10.1182/blood-2007-12-127878PubMedPubMedCentralCrossRef
13.
go back to reference Smith DK, Neal JJ, Holmberg SD: Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 1993, 328: 373-379. 10.1056/NEJM199302113280601PubMedCrossRef Smith DK, Neal JJ, Holmberg SD: Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 1993, 328: 373-379. 10.1056/NEJM199302113280601PubMedCrossRef
14.
go back to reference Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J: Seroepidemiology of the human polyomaviruses. J Gen Virol 2003, 84: 1499-1504. 10.1099/vir.0.18842-0PubMedCrossRef Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J: Seroepidemiology of the human polyomaviruses. J Gen Virol 2003, 84: 1499-1504. 10.1099/vir.0.18842-0PubMedCrossRef
15.
go back to reference Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, et al.: Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003,9(Suppl 1):47-53.PubMedCrossRef Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, et al.: Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003,9(Suppl 1):47-53.PubMedCrossRef
16.
go back to reference Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R: Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 2009, 361: 1075-1080. 10.1056/NEJMoa0810257PubMedCrossRef Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R: Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 2009, 361: 1075-1080. 10.1056/NEJMoa0810257PubMedCrossRef
17.
go back to reference Aksamit AJ: Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2008, 10: 178-185. 10.1007/s11940-008-0019-8PubMedCrossRef Aksamit AJ: Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2008, 10: 178-185. 10.1007/s11940-008-0019-8PubMedCrossRef
18.
go back to reference Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, et al.: Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 1998, 338: 1345-1351. 10.1056/NEJM199805073381903PubMedCrossRef Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, et al.: Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 1998, 338: 1345-1351. 10.1056/NEJM199805073381903PubMedCrossRef
19.
go back to reference De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, et al.: Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. Aids 2008, 22: 1759-1767. 10.1097/QAD.0b013e32830a5043PubMedCrossRef De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, et al.: Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. Aids 2008, 22: 1759-1767. 10.1097/QAD.0b013e32830a5043PubMedCrossRef
20.
go back to reference Royal W, Dupont B, McGuire D, Chang L, Goodkin K, Ernst T, Post MJ, Fish D, Pailloux G, Poncelet H, et al.: Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 2003, 9: 411-419. 10.1080/713831540PubMedCrossRef Royal W, Dupont B, McGuire D, Chang L, Goodkin K, Ernst T, Post MJ, Fish D, Pailloux G, Poncelet H, et al.: Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 2003, 9: 411-419. 10.1080/713831540PubMedCrossRef
21.
go back to reference Cettomai D, McArthur JC: Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 2009, 66: 255-258. 10.1001/archneurol.2008.557PubMedCrossRef Cettomai D, McArthur JC: Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 2009, 66: 255-258. 10.1001/archneurol.2008.557PubMedCrossRef
Metadata
Title
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
Authors
Christos Vaklavas
Elsa P Sotelo-Rafiq
Jordan Lovy
Miguel A Escobar
Apostolia M Tsimberidou
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-256

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.